Prestige Biopharma Ltd.

Prestige Biopharma Ltd. is a biopharmaceutical company primarily focused on the development, manufacturing, and commercialization of biosimilar medicines and novel biologics. Biosimilars are products that are highly similar to an already approved reference product, offering affordable therapeutic options, particularly in the realm of oncology and immune disorders. Prestige Biopharma's pipeline includes a range of biosimilars and new biologic candidates, with a notable focus on treatments for cancer, one of the most critical sectors in healthcare. The company operates with a keen emphasis on advancing healthcare accessibility through its commitment to innovation in biotechnology. Situated in the rapidly evolving biopharmaceutical sector, Prestige Biopharma plays a significant role in meeting global demands for cost-effective therapeutic alternatives. In doing so, it contributes directly to the healthcare industry by addressing crucial unmet needs and expanding treatment options for patients worldwide.